Regulation of mTORC1 and its impact on gene expression at a glance

Mathieu Laplante1, David M. Sabatini2
1Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, 2725 Chemin Ste-Foy, Québec, Qc, G1V 4G5, Canada.
2Whitehead Institute for Biomedical Research, Nine Cambridge Center

Tóm tắt

The mechanistic (or mammalian) target of rapamycin (mTOR) is a kinase that regulates key cellular functions linked to the promotion of cell growth and metabolism. This kinase, which is part of two protein complexes termed mTOR complex 1 (mTORC1) and 2 (mTORC2), has a fundamental role in coordinating anabolic and catabolic processes in response to growth factors and nutrients. Of the two mTOR complexes, mTORC1 is by far the best characterized. When active, mTORC1 triggers cell growth and proliferation by promoting protein synthesis, lipid biogenesis, and metabolism, and by reducing autophagy. The fact that mTORC1 deregulation is associated with several human diseases, such as type 2 diabetes, cancer, obesity and neurodegeneration, highlights its importance in the maintenance of cellular homeostasis. Over the last years, several groups observed that mTORC1 inhibition, in addition to reducing protein synthesis, deeply affects gene transcription. Here, we review the connections between mTORC1 and gene transcription by focusing on its impact in regulating the activation of specific transcription factors including including STAT3, SREBPs, PPARγ, PPARα, HIF1α, YY1–PGC1α and TFEB. We also discuss the importance of these transcription factors in mediating the effects of mTORC1 on various cellular processes in physiological and pathological contexts.

Từ khóa


Tài liệu tham khảo

Bakan, 2012, Connecting mTORC1 signaling to SREBP-1 activation., Curr. Opin. Lipidol., 23, 226, 10.1097/MOL.0b013e328352dd03

Bar-Peled, 2012, Ragulator is a GEF for the rag GTPases that signal amino acid levels to mTORC1., Cell, 150, 1196, 10.1016/j.cell.2012.07.032

Bentzinger, 2008, Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy., Cell Metab., 8, 411, 10.1016/j.cmet.2008.10.002

Blommaart, 1995, Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes., J. Biol. Chem., 270, 2320, 10.1074/jbc.270.5.2320

Brown, 1994, A mammalian protein targeted by G1-arresting rapamycin-receptor complex., Nature, 369, 756, 10.1038/369756a0

Brugarolas, 2003, TSC2 regulates VEGF through mTOR-dependent and -independent pathways., Cancer Cell, 4, 147, 10.1016/S1535-6108(03)00187-9

Cho, 2004, Regulation of adipocyte differentiation and insulin action with rapamycin., Biochem. Biophys. Res. Commun., 321, 942, 10.1016/j.bbrc.2004.07.050

Crespo, 2002, Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae., Microbiol. Mol. Biol. Rev., 66, 579, 10.1128/MMBR.66.4.579-591.2002

Cunningham, 2007, mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex., Nature, 450, 736, 10.1038/nature06322

Decker, 2000, Serine phosphorylation of STATs., Oncogene, 19, 2628, 10.1038/sj.onc.1203481

Dibble, 2012, TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1., Mol. Cell, 47, 535, 10.1016/j.molcel.2012.06.009

Düvel, 2010, Activation of a metabolic gene regulatory network downstream of mTOR complex 1., Mol. Cell, 39, 171, 10.1016/j.molcel.2010.06.022

Efeyan, 2013, Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival., Nature, 493, 679, 10.1038/nature11745

Gagnon, 2001, Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion., J. Cell. Physiol., 189, 14, 10.1002/jcp.1132

Goncharova, 2009, Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis., Mol. Pharmacol., 76, 766, 10.1124/mol.109.057042

Hannan, 2003, mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar transcription factor UBF., Mol. Cell. Biol., 23, 8862, 10.1128/MCB.23.23.8862-8877.2003

Hara, 1998, Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism., J. Biol. Chem., 273, 14484, 10.1074/jbc.273.23.14484

Harrison, 2009, Rapamycin fed late in life extends lifespan in genetically heterogeneous mice., Nature, 460, 392, 10.1038/nature08221

Horton, 2002, SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver., J. Clin. Invest., 109, 1125, 10.1172/JCI0215593

Hsu, 2011, The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling., Science, 332, 1317, 10.1126/science.1199498

Hudson, 2002, Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin., Mol. Cell. Biol., 22, 7004, 10.1128/MCB.22.20.7004-7014.2002

Inoki, 2002, TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling., Nat. Cell Biol., 4, 648, 10.1038/ncb839

Inoki, 2003, Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling., Genes Dev., 17, 1829, 10.1101/gad.1110003

Jacinto, 2004, Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive., Nat. Cell Biol., 6, 1122, 10.1038/ncb1183

Jimenez, 2010, Regulation of gene expression in hepatic cells by the mammalian Target of Rapamycin (mTOR)., PLoS ONE, 5, e9084, 10.1371/journal.pone.0009084

Kantidakis, 2010, mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1., Proc. Natl. Acad. Sci. USA, 107, 11823, 10.1073/pnas.1005188107

Keith, 2012, HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression., Nat. Rev. Cancer, 12, 9, 10.1038/nrc3183

Khamzina, 2005, Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance., Endocrinology, 146, 1473, 10.1210/en.2004-0921

Kim, 2004, regulation of peroxisome proliferator-activated receptor-gamma activity by mammalian target of rapamycin and amino acids in adipogenesis., Diabetes, 53, 2748, 10.2337/diabetes.53.11.2748

Kim, 1998, ADD1/SREBP1 activates PPARgamma through the production of endogenous ligand., Proc. Natl. Acad. Sci. USA, 95, 4333, 10.1073/pnas.95.8.4333

Kim, 2008, Regulation of TORC1 by Rag GTPases in nutrient response., Nat. Cell Biol., 10, 935, 10.1038/ncb1753

Kim, 2009, Signal transducer and activator of transcription 3 (STAT3) mediates amino acid inhibition of insulin signaling through serine 727 phosphorylation., J. Biol. Chem., 284, 35425, 10.1074/jbc.M109.051516

Kim, 2012, S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver., Hepatology, 55, 1727, 10.1002/hep.25537

Kortylewski, 2005, Targeting STAT3 affects melanoma on multiple fronts., Cancer Metastasis Rev., 24, 315, 10.1007/s10555-005-1580-1

Koyanagi, 2011, Ablation of TSC2 enhances insulin secretion by increasing the number of mitochondria through activation of mTORC1., PLoS ONE, 6, e23238, 10.1371/journal.pone.0023238

Lamming, 2012, Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity., Science, 335, 1638, 10.1126/science.1215135

Laplante, 2009, mTOR signaling at a glance., J. Cell Sci., 122, 3589, 10.1242/jcs.051011

Laplante, 2012, mTOR signaling in growth control and disease., Cell, 149, 274, 10.1016/j.cell.2012.03.017

Laplante, 2012, DEPTOR cell-autonomously promotes adipogenesis, and its expression is associated with obesity., Cell Metab., 16, 202, 10.1016/j.cmet.2012.07.008

Laughner, 2001, HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression., Mol. Cell. Biol., 21, 3995, 10.1128/MCB.21.12.3995-4004.2001

Le Bacquer, 2007, Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2., J. Clin. Invest., 117, 387, 10.1172/JCI29528

Lefebvre, 2006, Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis., J. Clin. Invest., 116, 571, 10.1172/JCI27989

Li, 2010, Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis., Proc. Natl. Acad. Sci. USA, 107, 3441, 10.1073/pnas.0914798107

Li, 2011, Role of S6K1 in regulation of SREBP1c expression in the liver., Biochem. Biophys. Res. Commun., 412, 197, 10.1016/j.bbrc.2011.07.038

Ma, 2005, Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis., Cell, 121, 179, 10.1016/j.cell.2005.02.031

Ma, 2010, Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade., J. Clin. Invest., 120, 103, 10.1172/JCI37964

Majmundar, 2010, Hypoxia-inducible factors and the response to hypoxic stress., Mol. Cell, 40, 294, 10.1016/j.molcel.2010.09.022

Manning, 2007, AKT/PKB signaling: navigating downstream., Cell, 129, 1261, 10.1016/j.cell.2007.06.009

Manning, 2002, Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway., Mol. Cell, 10, 151, 10.1016/S1097-2765(02)00568-3

Martina, 2012, MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB., Autophagy, 8, 903, 10.4161/auto.19653

Mayer, 2004, mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability., Genes Dev., 18, 423, 10.1101/gad.285504

Menendez, 2007, Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis., Nat. Rev. Cancer, 7, 763, 10.1038/nrc2222

Miller, 2011, Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice., J. Gerontol., 66A, 191, 10.1093/gerona/glq178

Okuda, 1987, Age-related change in ketone body metabolism: diminished glucagon effect on ketogenesis in adult rats., Endocrinology, 120, 2152, 10.1210/endo-120-5-2152

Onda, 2002, Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway., Mol. Cell. Neurosci., 21, 561, 10.1006/mcne.2002.1184

Owen, 2012, Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase., Proc. Natl. Acad. Sci. USA, 109, 16184, 10.1073/pnas.1213343109

Palmieri, 2011, Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways., Hum. Mol. Genet., 20, 3852, 10.1093/hmg/ddr306

Peng, 2002, The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation., Mol. Cell. Biol., 22, 5575, 10.1128/MCB.22.15.5575-5584.2002

Petersen, 2003, Mitochondrial dysfunction in the elderly: possible role in insulin resistance., Science, 300, 1140, 10.1126/science.1082889

Peterson, 2011, mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway., Cell, 146, 408, 10.1016/j.cell.2011.06.034

Polak, 2008, Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration., Cell Metab., 8, 399, 10.1016/j.cmet.2008.09.003

Porstmann, 2008, SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth., Cell Metab., 8, 224, 10.1016/j.cmet.2008.07.007

Potter, 2002, Akt regulates growth by directly phosphorylating Tsc2., Nat. Cell Biol., 4, 658, 10.1038/ncb840

Roczniak-Ferguson, 2012, The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis., Sci. Signal., 5, ra42, 10.1126/scisignal.2002790

Romanino, 2011, Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function., Proc. Natl. Acad. Sci. USA, 108, 20808, 10.1073/pnas.1111448109

Rosen, 2006, Adipocyte differentiation from the inside out., Nat. Rev. Mol. Cell Biol., 7, 885, 10.1038/nrm2066

Roux, 2004, Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase., Proc. Natl. Acad. Sci. USA, 101, 13489, 10.1073/pnas.0405659101

Rubinsztein, 2011, Autophagy and aging., Cell, 146, 682, 10.1016/j.cell.2011.07.030

Sabatini, 1994, RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs., Cell, 78, 35, 10.1016/0092-8674(94)90570-3

Sabers, 1995, Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells., J. Biol. Chem., 270, 815, 10.1074/jbc.270.2.815

Sancak, 2007, PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase., Mol. Cell, 25, 903, 10.1016/j.molcel.2007.03.003

Sancak, 2008, The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1., Science, 320, 1496, 10.1126/science.1157535

Sancak, 2010, Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids., Cell, 141, 290, 10.1016/j.cell.2010.02.024

Sanguino, 2004, Lack of hypotriglyceridemic effect of gemfibrozil as a consequence of age-related changes in rat liver PPARalpha., Biochem. Pharmacol., 67, 157, 10.1016/j.bcp.2003.08.034

Sarbassov, 2004, Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton., Curr. Biol., 14, 1296, 10.1016/j.cub.2004.06.054

Sarbassov, 2006, Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB., Mol. Cell, 22, 159, 10.1016/j.molcel.2006.03.029

Sarkar, 2008, Small molecule enhancers of autophagy for neurodegenerative diseases., Mol. Biosyst., 4, 895, 10.1039/b804606a

Sastre, 1996, Aging of the liver: age-associated mitochondrial damage in intact hepatocytes., Hepatology, 24, 1199, 10.1002/hep.510240536

Sengupta, 2010, mTORC1 controls fasting-induced ketogenesis and its modulation by ageing., Nature, 468, 1100, 10.1038/nature09584

Settembre, 2011, TFEB links autophagy to lysosomal biogenesis., Science, 332, 1429, 10.1126/science.1204592

Settembre, 2012, A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB., EMBO J., 31, 1095, 10.1038/emboj.2012.32

Shende, 2011, Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice., Circulation, 123, 1073, 10.1161/CIRCULATIONAHA.110.977066

Shor, 2010, Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells., J. Biol. Chem., 285, 15380, 10.1074/jbc.M109.071639

Singh, 2011, Autophagy in the cellular energetic balance., Cell Metab., 13, 495, 10.1016/j.cmet.2011.04.004

Tee, 2003, Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb., Curr. Biol., 13, 1259, 10.1016/S0960-9822(03)00506-2

Thedieck, 2007, PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis., PLoS ONE, 2, e1217, 10.1371/journal.pone.0001217

Tremblay, 2007, Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance., Proc. Natl. Acad. Sci. USA, 104, 14056, 10.1073/pnas.0706517104

Tzatsos, 2006, Nutrients suppress phosphatidylinositol 3-kinase/Akt signaling via raptor-dependent mTOR-mediated insulin receptor substrate 1 phosphorylation., Mol. Cell. Biol., 26, 63, 10.1128/MCB.26.1.63-76.2006

Um, 2004, Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity., Nature, 431, 200, 10.1038/nature02866

Vander Haar, 2007, Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40., Nat. Cell Biol., 9, 316, 10.1038/ncb1547

Wang, 2007, PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding., J. Biol. Chem., 282, 20036, 10.1074/jbc.M702376200

Wang, 2011, The mammalian target of rapamycin regulates cholesterol biosynthetic gene expression and exhibits a rapamycin-resistant transcriptional profile., Proc. Natl. Acad. Sci. USA, 108, 15201, 10.1073/pnas.1103746108

Weichhart, 2008, The TSC-mTOR signaling pathway regulates the innate inflammatory response., Immunity, 29, 565, 10.1016/j.immuni.2008.08.012

Yecies, 2011, Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways., Cell Metab., 14, 21, 10.1016/j.cmet.2011.06.002

Yokogami, 2000, Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR., Curr. Biol., 10, 47, 10.1016/S0960-9822(99)00268-7

Yu, 2008, Critical role of phosphoinositide 3-kinase cascade in adipogenesis of human mesenchymal stem cells., Mol. Cell. Biochem., 310, 11, 10.1007/s11010-007-9661-9

Yu, 2011, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling., Science, 332, 1322, 10.1126/science.1199484

Zhang, 2009, Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway., PLoS ONE, 4, e6189, 10.1371/journal.pone.0006189

Zhou, 2007, Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance., Proc. Natl. Acad. Sci. USA, 104, 16158, 10.1073/pnas.0702596104

Zinzalla, 2011, Activation of mTORC2 by association with the ribosome., Cell, 144, 757, 10.1016/j.cell.2011.02.014

Zoncu, 2011, mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase., Science, 334, 678, 10.1126/science.1207056